For much of 2025, UnitedHealth Group (UNH) looked like a company under siege as higher medical costs and weaker margins rattled investors. UNH stock sold off sharply, and questions emerged around the company’s earnings outlook as well as the health of its long-standing growth story.
That picture is starting to improve in 2026. UnitedHealth's latest results showed a clear turnaround in profitability as it generated $112 billion in revenue and $8 billion in earnings from operations. Management also raised the company's full-year adjusted EPS outlook to a range of $19.50 to $20 and increased its operating cash flow forecast to about $24 billion. Those moves suggest UnitedHealth sees its recovery as more than a short-term earnings rebound.
